sivextro- tedizolid phosphate tablet, film coated sivextro- tedizolid phosphate injection, powder, lyophilized, for solution
merck sharp & dohme llc - tedizolid phosphate (unii: o7drj6r4dw) (tedizolid - unii:97hlq82ngl) - tedizolid phosphate 200 mg - sivextro® is an oxazolidinone-class antibacterial indicated in adult and pediatric patients 12 years of age and older for the treatment of acute bacterial skin and skin structure infections (absssi) caused by susceptible isolates of the following gram-positive microorganisms: staphylococcus aureus (including methicillin-resistant [mrsa] and methicillin-susceptible [mssa] isolates), streptococcus pyogenes , streptococcus agalactiae , streptococcus anginosus group (including streptococcus anginosus , streptococcus intermedius , and streptococcus constellatus ), and enterococcus faecalis . to reduce the development of drug-resistant bacteria and maintain the effectiveness of sivextro and other antibacterial drugs, sivextro should be used only to treat absssi that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemio
sivextro- tedizolid phosphate tablet, film coated sivextro- tedizolid phosphate injection, powder, lyophilized, for solution
nabriva therapeutics us, inc. - tedizolid phosphate (unii: o7drj6r4dw) (tedizolid - unii:97hlq82ngl) - sivextro® is an oxazolidinone-class antibacterial indicated in adult and pediatric patients 12 years of age and older for the treatment of acute bacterial skin and skin structure infections (absssi) caused by susceptible isolates of the following gram-positive microorganisms: staphylococcus aureus (including methicillin-resistant [mrsa] and methicillin-susceptible [mssa] isolates), streptococcus pyogenes , streptococcus agalactiae , streptococcus anginosus group (including streptococcus anginosus , streptococcus intermedius , and streptococcus constellatus ), and enterococcus faecalis . to reduce the development of drug-resistant bacteria and maintain the effectiveness of sivextro and other antibacterial drugs, sivextro should be used only to treat absssi that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemio
賽威樂 凍晶注射劑
台灣拜耳股份有限公司 台北市信義路五段7號53-54樓 (23167184) - tedizolid phosphate - 凍晶注射劑 - tedizolid phosphate (9200042100) mg - tedizolid - 治療成人(18歲及以上)由具感受性的格蘭氏陽性細菌所引起的急性細菌性皮膚和皮膚組織感染
賽威樂 膜衣錠 200毫克
臺灣拜耳股份有限公司 台北市信義區信義路五段7號台北101大樓之53至54樓 (23167184) - tedizolid phosphate - 膜衣錠 - tedizolid phosphate (9200042100) mg - tedizolid - 治療成人18歲及以上由具感受性的格蘭氏陽性細菌所引起的急性細菌性皮膚和皮膚組織感染
sivextro
merck sharp & dohme b.v. - phosphate tédizolid - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.
sivextro
merck sharp & dohme b.v. - tedizolid phosphate - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.
sivextro 200mg powder for concentrate for solution for infusion vials
merck sharp & dohme ltd - tedizolid phosphate - powder for solution for infusion - 200mg
sivextro 200mg tablets
merck sharp & dohme ltd - tedizolid phosphate - tablet - 200mg
sivextro film-coated tablet 200mg
merck sharp & dohme (malaysia) sdn bhd - tedizolid phosphate -
sivextro tablet
merck canada inc - tedizolid phosphate - tablet - 200mg - tedizolid phosphate 200mg - oxazolidinones